GlaxoSmithKline(DE:GS71)
€22.29-0.10 (-0.45%)
DE:GS71
GlaxoSmithKline earnings date
€22.29
At close:-0.10 (-0.45%)
GlaxoSmithKline (GS71) Q2 2021 Earnings Report
6 Followers
DE:GS71 Q2 2021 EPS Results
- Actual EPS
- EUR 0.34
- Consensus EPS
- EUR 0.18
- Beat/Miss
- Beat by +EUR 0.16
- One Year Ago EPS
- EUR 0.23
DE:GS71 Q2 2021 Revenue Results
- Actual Revenue
- EUR 9.69B
- Expected Revenue
- EUR 6.91B
- Beat/Miss
- Beat by +EUR 2.78B
- YoY Revenue Growth
- +6.14%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 07/28/2021
- Time
- Before Open
- Conference Call
- Wednesday, July 28, 2021
DE:GS71 Upcoming Earnings
GlaxoSmithKline's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:GS71 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 0.33- | 0.31 | ― | ― |
| Oct 28, 2026 | 2026 (Q3) | 0.600.65 | 0.66 | -0.73% (-0.00) | |
| Jul 28, 2026 | 2026 (Q2) | 0.560.60 | 0.56 | 8.60% (+0.05) | |
| Apr 29, 2026 | 2026 (Q1) | 0.520.56 | 0.54 | 3.56% (+0.02) | |
| Feb 04, 2026 | 2025 (Q4) | 0.290.31 | 0.28 | 9.91% (+0.03) | |
| Oct 29, 2025 | 2025 (Q3) | 0.560.66 | 0.6 | 10.66% (+0.06) | |
| Apr 30, 2025 | 2025 (Q1) | 0.480.54 | 0.52 | 4.18% (+0.02) | |
| Feb 05, 2025 | 2024 (Q4) | 0.240.28 | 0.35 | -19.72% (-0.07) | |
| Oct 30, 2024 | 2024 (Q3) | 0.530.60 | 0.6 | -1.39% (-0.01) | |
| Jul 31, 2024 | 2024 (Q2) | 0.460.52 | 0.46 | 11.86% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

